Structures by: Zeng X. H.
Total: 40
C26H31BrN2O3
C26H31BrN2O3
Organic letters (2015) 17, 9 2234-2237
a=9.6121(18)Å b=11.761(2)Å c=13.648(3)Å
α=98.331(3)° β=109.571(3)° γ=113.637(3)°
C42H33CuF3FeN4P2,ClO4
C42H33CuF3FeN4P2,ClO4
New Journal of Chemistry (2019) 43, 10 4261
a=11.3107(8)Å b=12.1874(8)Å c=16.3416(11)Å
α=93.122(2)° β=106.817(2)° γ=107.096(2)°
C42H32CuF3FeN4P2,H2O
C42H32CuF3FeN4P2,H2O
New Journal of Chemistry (2019) 43, 10 4261
a=11.0101(6)Å b=11.7274(6)Å c=15.4169(8)Å
α=82.9510(10)° β=72.2160(10)° γ=84.2850(10)°
C43H35CuF3FeN4P2,ClO4,CH2Cl2
C43H35CuF3FeN4P2,ClO4,CH2Cl2
New Journal of Chemistry (2019) 43, 10 4261
a=14.6620(9)Å b=17.0542(11)Å c=17.7433(11)Å
α=90° β=95.218(2)° γ=90°
C43H34CuF3FeN4P2
C43H34CuF3FeN4P2
New Journal of Chemistry (2019) 43, 10 4261
a=11.6340(18)Å b=14.542(2)Å c=15.262(2)Å
α=63.638(3)° β=67.654(3)° γ=87.745(4)°
C43H35CuF3FeN4P2,ClO4
C43H35CuF3FeN4P2,ClO4
New Journal of Chemistry (2019) 43, 10 4261
a=12.7414(7)Å b=18.5376(9)Å c=17.2280(8)Å
α=90° β=92.1780(10)° γ=90°
C45H42CuFeN4P2,ClO4,CH2Cl2
C45H42CuFeN4P2,ClO4,CH2Cl2
New Journal of Chemistry (2019) 43, 10 4261
a=12.2325(7)Å b=12.7959(7)Å c=16.1249(9)Å
α=79.572(2)° β=68.8210(10)° γ=78.8600(10)°
C43H34CuF3FeN4P2
C43H34CuF3FeN4P2
New Journal of Chemistry (2019) 43, 10 4261
a=12.3724(10)Å b=12.4276(11)Å c=14.3099(12)Å
α=89.666(2)° β=72.705(2)° γ=70.890(2)°
C83H75Cl3Cu2N5O8P4
C83H75Cl3Cu2N5O8P4
Dalton Trans. (2017)
a=17.376(4)Å b=21.438(4)Å c=24.102(5)Å
α=65.81(3)° β=70.12(3)° γ=88.58(3)°
C48H49BCuF4N5OP2
C48H49BCuF4N5OP2
Dalton Trans. (2017)
a=11.6511(6)Å b=12.0536(6)Å c=17.6908(8)Å
α=74.6690(10)° β=84.7700(10)° γ=76.6300(10)°
C44H36Cl3CuF3N5O4P2
C44H36Cl3CuF3N5O4P2
Dalton Trans. (2017)
a=13.7615(14)Å b=18.8631(19)Å c=34.938(4)Å
α=90.00° β=90.00° γ=90.00°
C48H49ClCuN5O5P2
C48H49ClCuN5O5P2
Dalton Trans. (2017)
a=11.632(2)Å b=11.837(2)Å c=17.411(3)Å
α=75.43(3)° β=85.99(3)° γ=76.98(3)°
C79H63ClCu2F3N5O4P4
C79H63ClCu2F3N5O4P4
Dalton Trans. (2017)
a=15.271(3)Å b=19.673(4)Å c=45.524(9)Å
α=90.00° β=90.00° γ=90.00°
C48H49CuF6N5OP3
C48H49CuF6N5OP3
Dalton Trans. (2017)
a=11.8794(6)Å b=12.0238(7)Å c=18.0436(10)Å
α=74.0830(10)° β=85.8980(10)° γ=76.8040(10)°
3-Benzyl-2-butylamino-5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one
C21H25N3OS
Acta Crystallographica Section E (2006) 62, 1 o228-o229
a=11.7759(11)Å b=9.2747(9)Å c=18.6871(18)Å
α=90.00° β=107.760(2)° γ=90.00°
3-Isopropyl-2-propoxy-5,6,7,8-tetrahydro-1-benzothieno[2,3-d]pyrimidin-4(3H)-one
C16H22N2O2S
Acta Crystallographica Section E (2005) 61, 12 o4336-o4337
a=10.1586(9)Å b=14.4156(13)Å c=11.9245(11)Å
α=90.00° β=113.675(2)° γ=90.00°
3-(2-Aminophenyl)-2-methylsulfanyl-5,6,7,8- tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one
C17H17N3OS2
Acta Crystallographica Section E (2005) 61, 12 o4160-o4161
a=11.7686(10)Å b=13.4861(11)Å c=11.2137(10)Å
α=90.00° β=112.552(2)° γ=90.00°
2-(4-Chlorophenoxy)-3-isopropyl-5,6,7,8-tetrahydro-2- benzothieno[2,3-d]pyrimidin-4(3H)-one
C19H19ClN2O2S
Acta Crystallographica Section E (2006) 62, 2 o731-o732
a=13.2129(12)Å b=5.7350(5)Å c=13.2120(12)Å
α=90.00° β=115.13° γ=90.00°
3-Isopropyl-2-phenoxy-5,6,7,8-tetrahydro-1- benzothieno[2,3-d]pyrimidin-4(3H)-one
C19H20N2O2S
Acta Crystallographica Section E (2006) 62, 2 o532-o533
a=12.4411(15)Å b=5.8030(7)Å c=13.2870(16)Å
α=90.00° β=113.994(2)° γ=90.00°
6-Isopropyl-5-(3-nitrophenoxy)-3-phenyl-3H-1,2,3-triazolo[4,5-d]pyrimidin- 7(6H)-one
C19H16N6O4
Acta Crystallographica Section E (2006) 62, 11 o5038-o5040
a=18.2261(14)Å b=11.6455(9)Å c=18.1673(14)Å
α=90.00° β=93.7370(10)° γ=90.00°
1-Benzyl-5-[2-(2,3-dichloro-phenyl)-3-isopropyl-isoureido] -1H-1,2,3-triazole-4-carboxylic acid ethyl ester
C22H23Cl2N5O3
Acta Crystallographica Section E (2006) 62, 11 o5174-o5175
a=9.1692(8)Å b=10.1164(9)Å c=25.360(2)Å
α=90.00° β=91.639(2)° γ=90.00°
3-Butyl-2-(piperidin-1-yl)-5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin- 4(3H)-one
C19H27N3OS
Acta Crystallographica Section E (2007) 63, 11 o4365-o4365
a=9.8979(8)Å b=10.3679(9)Å c=10.9645(9)Å
α=113.5370(10)° β=107.6790(10)° γ=100.1670(10)°
2-(2,4-Dichloro-6-methylphenoxy)-3-isopropyl-5,6,7,8- tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one
C20H20Cl2N2O2S
Acta Crystallographica Section E (2007) 63, 3 o1142-o1144
a=8.3028(8)Å b=18.0664(17)Å c=13.7999(13)Å
α=90.00° β=100.954(2)° γ=90.00°
3-Isopropyl-2-morpholino-5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one
C17H23N3O2S
Acta Crystallographica Section E (2007) 63, 6 o3004-o3004
a=25.8379(12)Å b=8.0874(6)Å c=20.5316(10)Å
α=90.00° β=128.8570(10)° γ=90.00°
3-Butyl-2-morpholino-5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one
C18H25N3O2S
Acta Crystallographica Section E (2007) 63, 12 o4840-o4840
a=27.2898(17)Å b=27.2898(9)Å c=13.3909(9)Å
α=90.00° β=90.00° γ=120.00°
2-Isopropylamino-1-phenyl-1H-imidazol-5(4H)-one
C12H15N3O
Acta Crystallographica Section E (2006) 62, 12 o5704-o5706
a=19.076(3)Å b=7.6881(10)Å c=32.241(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-(3,3-dibutylthioureido)-4,5,6,7-tetrahydrobenzo[<i>b</i>]thiophene- 3-carboxylate
C20H32N2O2S2
Acta Crystallographica Section E (2009) 65, 12 o3094-o3095
a=10.9311(11)Å b=21.715(3)Å c=9.6841(3)Å
α=90.00° β=107.711(12)° γ=90.00°
3-Isopropyl-2-<i>p</i>-tolyloxy-5,6,7,8-tetrahydro-1- benzothieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one
C20H22N2O2S
Acta Crystallographica Section E (2009) 65, 5 o1142-o1143
a=13.2367(7)Å b=5.7493(3)Å c=13.4306(7)Å
α=90.00° β=115.858(4)° γ=90.00°
6-Isopropyl-5-methoxy-3-phenyl-3<i>H</i>-1,2,3-triazolo[4,5- <i>d</i>]pyrimidin-7(6<i>H</i>)-one
C14H15N5O2
Acta Crystallographica Section E (2010) 66, 11 o2947-o2948
a=14.921(2)Å b=6.7989(11)Å c=13.839(2)Å
α=90.00° β=90.00° γ=90.00°
5-(4-Chlorophenoxy)-6-isopropyl-3-phenyl-3<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidin-7(6<i>H</i>)-one
C19H16ClN5O2
Acta Crystallographica Section E (2009) 65, 10 o2583-o2584
a=16.8429(3)Å b=11.7890(2)Å c=18.8309(3)Å
α=90.00° β=91.737(2)° γ=90.00°
2-(4-Bromo-phenoxy)-3-isopropyl-5,6,7,8-tetrahydro -benzothieno[2,3-d]pyrimidin-4(3H)-one
C19H19BrN2O2S
Acta Crystallographica Section E (2008) 64, 12 o2404
a=13.3957(7)Å b=5.7366(3)Å c=13.3956(7)Å
α=90.00° β=115.5410(10)° γ=90.00°
6-Isopropyl-3-phenyl-5-(<i>p</i>-tolyloxy)-3<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidin-7(6<i>H</i>)-one
C20H19N5O2
Acta Crystallographica Section E (2009) 65, 11 o2653-o2654
a=10.2335(6)Å b=21.8532(12)Å c=16.7441(9)Å
α=90.00° β=90.00° γ=90.00°
6-Butyl-5-(4-methoxyphenoxy)-3-phenyl-3<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidin-7(6<i>H</i>)-one
C21H21N5O3
Acta Crystallographica Section E (2009) 65, 12 o3032-o3033
a=11.5167(13)Å b=12.4026(13)Å c=14.9353(16)Å
α=78.795(2)° β=76.207(2)° γ=76.360(2)°
6-Butyl-5-(4-methylphenoxy)-3-phenyl-3<i>H</i>-1,2,3- triazolo[4,5-<i>d</i>]pyrimidin-7(6<i>H</i>)-one
C21H21N5O2
Acta Crystallographica Section E (2010) 66, 11 o2990-o2991
a=11.0954(10)Å b=16.4478(15)Å c=11.3484(11)Å
α=90.00° β=107.6430(10)° γ=90.00°
3-Benzyl-6-butyl-5-propyl-3<i>H</i>-1,2,3-triazolo[4,5-<i>d</i>]pyrimidin- 7(6<i>H</i>)-one
C18H23N5O2
Acta Crystallographica Section E (2010) 66, 12 o3140-o3141
a=28.328(6)Å b=14.818(3)Å c=8.7995(16)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 1-benzyl-5-{[(isopropylamino)(3-nitrophenoxy)methylidene]amino}- 1<i>H</i>-1,2,3-triazole-4-carboxylate
C22H24N6O5
Acta Crystallographica Section E (2010) 66, 12 o3207-o3208
a=11.5019(7)Å b=14.5616(9)Å c=14.1758(9)Å
α=90.00° β=106.3840(10)° γ=90.00°
2(C7H2O8SU),C36H24N6Ni
2(C7H2O8SU),C36H24N6Ni
Crystal Growth & Design (2015) 15, 1 10
a=16.4997(8)Å b=17.2919(8)Å c=18.0359(9)Å
α=90.00° β=90.00° γ=90.00°
C18H6O16S3U2,C36H24FeN6,C6H2O4S,6(O)
C18H6O16S3U2,C36H24FeN6,C6H2O4S,6(O)
Crystal Growth & Design (2015) 15, 1 10
a=13.8588(8)Å b=15.8192(9)Å c=17.8350(10)Å
α=67.6880(10)° β=68.6860(10)° γ=76.1130(10)°
C24H12O16U2,2(C24H16ClCuN4),5(O)
C24H12O16U2,2(C24H16ClCuN4),5(O)
Crystal Growth & Design (2015) 15, 1 10
a=12.9801(8)Å b=34.096(2)Å c=16.3847(10)Å
α=90.00° β=94.9230(10)° γ=90.00°
C18H6O16S3U2,C12H14N2
C18H6O16S3U2,C12H14N2
Crystal Growth & Design (2015) 15, 1 10
a=12.420(3)Å b=18.132(4)Å c=16.188(3)Å
α=90.00° β=104.28(3)° γ=90.00°